CLINICAL SUPPLY MANAGEMENT ARTICLES
The End Of Just-In-Time? Why Clinical Trial Supply Chains Are Rethinking Inventory Strategy
Clinical trials are too unpredictable for inventory strategies built on fixed assumptions. Learn why agility, visibility and smarter buffers are becoming essential to supply planning.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Determine the best IRT/RTSM design for your trial through consideration of the user, data collection, and future-proofing.
-
Explore modern decentralized trials that bring the supply chain into the patient experience. and including the pros and cons of direct-to-patient models.
-
Randomization & trial supply management (RTSM) are critical functions of clinical trial IRT systems, supporting patient randomization plus managing drug inventory, site resupply, and participant dispensation.
-
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
Sponsors are recognizing the potential benefits of decentralized clinical trials, including reduced operational costs and improved recruitment and retention of more diverse patient populations.
-
Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.
-
Examine how the next generation of therapies is disrupting supply chain logistics and explore solutions for the complexities within cell and gene therapies.